NG BIOTECH AT MEDICA, MESSE DUSSELDORF – NOVEMBER 15-18
From the 15th to the 18th of November, NG Biotech will be participating at the world forum for medicine, MEDICA 2021 in Messe Düsseldorf.
NG BIOTECH EXPANDS SENIOR MANAGEMENT TEAM TO CONTINUE IMPRESSIVE GROWTH TREND
NG Biotech S.A.S. (NG) announced today the appointment of Fabio Baglioni as Chief Commercial Officer (CCO) to spearhead the next phase of the company’s ambitious growth strategy.
NG BIOTECH AT ARAB HEALTH & MEDLAB, DUBAI – JUNE 2021
Arab Health Exhibition is one of the world major exhibitions in the #health sector and the largest trade fair in the Middle East and Asia.
Meet us at BIO Europe Spring Digital, on March 22-25
BIO Europe Spring is the first business convention dedicated to healthcare biotechnologies and the pharmaceutical industry in Europe where companies, investors and research and development players meet.
NG-Test® IgG-IgM COVID-19 obtains TROD status
NG Biotech has obtained the Rapid Diagnostic Orientation Test (TROD) label for its NG-Test® IgG-IgM COVID-19 serological test following the ministerial decree of the 10th of July.
Covid 19 tests: an order from the French Ministry of Health
Visiting NG Biotech, the Minister of Higher Education, Research and Innovation announces the order for 1.5 million tests for the Directorate General of Health.
Covid-19 test: support from the French Ministry of the Armed Forces
The Ministry of the Armed Forces supports and finances the Covid-19 screening test project carried by NG Biotech.